Nine years after he underwent treatment for non-Hodgkin’s lymphoma, a potentially fatal but treatable form of cancer, Microsoft co-founder Paul Allen says the disease has returned. On Twitter and in… Read More
A study published today on a Juno Therapeutics immunotherapy treatment for blood cancers shows that the drug and others like it could be more effective and less toxic than other treatments. The… Read More